insulin
Troglitazone exerts an antihyperglycemic activity in a       dose-dependent manner between 200 and 600 mg/day in type 2 diabetic patients       treated with diet alone, sulfonylureas, or insulin.
Troglitazone exerts an antihyperglycemic activity in a       dose-dependent manner between 200 and 600 mg/day in type 2 diabetic  @OBJECT$         @PREDICAT$  with diet alone, sulfonylureas, or  @SUBJECT$ .